The use of sumatriptan in patients on monoamine oxidase inhibitors

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neurology

• Publication date

  1995-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.45.6.1039PMID 7783861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver.

  1994cited by this paper
• Monoamine oxidase inhibition in the treatment of migraine.

  1969cited by this paper

• The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression

  2022cites this paper
• The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes

  2021cites this paper
• Pharmacokinetics II: 14C-Labelled Microdosing in Assessing Drug Pharmacokinetics at Phase 0

  2010cites this paper
• Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect

  2010cites this paper
• MAO inhibitors: Risks, benefits, and lore

  2010cites this paper
• The triptans

  2009cites this paper
• Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials

  2002cites this paper
• The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.

  1999cites this paper
• Consistency of Response To Sumatriptan Nasal Spray Across Patient Subgroups and Migraine Types

  1998influential citation
• Sumatriptan Contraindications and the Serotonin Syndrome

  1998cites this paper
• An overview of the diagnosis and pharmacologic treatment of migraine.

  1996cites this paper